Recombinant
RabMAb

Recombinant Anti-HuR / ELAVL1 antibody [EPR17397] (ab200342)

Rabbit recombinant monoclonal HuR / ELAVL1 antibody [EPR17397]. Validated in WB, IP, IHC, Flow Cyt, ICC/IF and tested in Mouse, Rat, Human. Cited in 4 publication(s).

Publishing research using ab200342? Please let us know so that we can cite the reference in this datasheet.

ab200342 has been referenced in 5 publications.

  • Lv Z  et al. Interaction between C2ORF68 and HuR in human colorectal cancer. Oncol Rep 41:1918-1928 (2019). PubMed: 30664176
  • Qin J  et al. Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity. Biomed Pharmacother 105:758-765 (2018). PubMed: 29909343
  • Yu D  et al. RNA-binding protein HuR promotes bladder cancer progression by competitively binding to the long noncoding HOTAIR with miR-1. Onco Targets Ther 10:2609-2619 (2017). PubMed: 28553126
  • Khalaj K  et al. A balancing act: RNA binding protein HuR/TTP axis in endometriosis patients. Sci Rep 7:5883 (2017). PubMed: 28724967
  • Wang N  et al. A HuR/TGF-ß1 feedback circuit regulates airway remodeling in airway smooth muscle cells. Respir Res 17:117 (2016). PubMed: 27658983

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up